Conflict of Interest Statement
Which Nontraditional Outcomes Should Be Measured in Healthcare Decision-Making in Schizophrenia? A Systematic Review
Version of Record online: 7 FEB 2012
© 2012 Wiley Periodicals, Inc.
Perspectives in Psychiatric Care
Volume 48, Issue 4, pages 198–207, October 2012
How to Cite
Vieta, A., Badia, X., Álvarez, E. and Sacristán, J. A. (2012), Which Nontraditional Outcomes Should Be Measured in Healthcare Decision-Making in Schizophrenia? A Systematic Review. Perspectives in Psychiatric Care, 48: 198–207. doi: 10.1111/j.1744-6163.2011.00325.x
Ms. Vieta and Dr. Badia report receiving honoraria or consulting fees from Lilly. Dr. Álvarez reports receiving honoraria fees from Lilly for his participation in clinical trials and consulting activities. Dr. Sacristán is an employee of Eli Lilly and Company. The authors have indicated that they have no other conflicts of interest regarding the content of this article.
This research was supported by Lilly S.A. (Madrid, Spain).
- Issue online: 25 SEP 2012
- Version of Record online: 7 FEB 2012
- First Received May 24, 2011; Final Revision received October 23, 2011; Accepted for publication October 24, 2011.
Table S1. Studies Included in the Systematic Review
Table S2. Patient-Reported Outcomes
Table S3. Economic Outcomes
|ppc325_sm_TabS1-3.doc||457K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.